WEIGHT LOSS

Retatrutide

10mg — Research Grade

Triple agonist targeting GLP-1, GIP, and Glucagon receptors for next-generation metabolic research. Entry-level 10mg vial for researchers beginning titration protocols or running shorter studies. Retatrutide is the first triple-action incretin, studied for its powerful effects on appetite regulation, fat oxidation, and energy expenditure — outperforming single and dual agonists in clinical trials.

SKU: RT10